GENETIC-CHARACTERIZATION OF THE VACCINIA VIRUS-DNA POLYMERASE - CYTOSINE-ARABINOSIDE RESISTANCE REQUIRES A VARIABLE LESION CONFERRING PHOSPHONOACETATE RESISTANCE IN CONJUNCTION WITH AN INVARIANT MUTATION LOCALIZED TO THE 3'-5' EXONUCLEASE DOMAIN
Ja. Taddie et P. Traktman, GENETIC-CHARACTERIZATION OF THE VACCINIA VIRUS-DNA POLYMERASE - CYTOSINE-ARABINOSIDE RESISTANCE REQUIRES A VARIABLE LESION CONFERRING PHOSPHONOACETATE RESISTANCE IN CONJUNCTION WITH AN INVARIANT MUTATION LOCALIZED TO THE 3'-5' EXONUCLEASE DOMAIN, Journal of virology, 67(7), 1993, pp. 4323-4336
In this report, we describe the isolation, molecular genetic mapping,
and phenotypic characterization of vaccinia virus mutants resistant to
cytosine arabinoside (araC) and phosphonoacetic acid (PAA). At 37-deg
rees-C, 8 muM araC was found to prevent macroscopic plaque formation b
y wild-type virus and to cause a 10(4)-fold reduction in viral yield.
Mutants resistant to 8 muM araC were selected by serial passage of a c
hemically mutagenized viral stock in the presence of drug. Because rec
overy of mutants required that initial passages be performed under les
s stringent selective conditions, and because plaque-purified isolates
were found to be cross-resistant to 200 mug of PAA per ml, it seemed
likely that resistance to araC required more than one genetic lesion.
This hypothesis was confirmed by genetic and physical mapping of the r
esponsible mutations. PAA(r) was accorded by the acquisition of one of
three G-A transitions in the DNA polymerase gene which individually a
lter cysteine 356 to tyrosine, glycine 372 to aspartic acid, or glycin
e 380 to serine. AraC(r) was found to require one of these substitutio
ns plus an additional T-C transition within codon 171 of the DNA polym
erase gene, a change which replaces the wild-type phenylalanine with s
erine. Congenic viral stocks carrying one of the three PAA(r) lesions,
either alone or in conjunction with the upstream araC(r) lesion, in a
n otherwise wild-type background were generated. The PAA(r) mutations
conferred nearly complete resistance to PAA, a slight degree of resist
ance to araC, hypersensitivity to aphidicolin, and decreased spontaneo
us mutation frequency. Addition of the mutation at codon 171 significa
ntly augmented araC resistance and aphidicolin hypersensitivity but ca
used no further change in mutation frequency. Several lines of evidenc
e suggest that the PAA(r) mutations primarily affect the deoxynucleosi
de triphosphate-binding site, whereas the codon 171 mutation, lying wi
thin a conserved motif associated with 3'-5' exonuclease function, is
postulated to affect the proofreading exonuclease of the DNA polymeras
e.